Want to join the conversation?
U.S. FDA approves $AGN and Gedeon Richter's VRAYLAR (cariprazine) capsules. This drug will address the unmet need for the treatment of bipolar I disorder and schizophrenia in adults. In the U.S. alone around five million people are affected by these disorders and will benefit from this drug approval.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.